NDC 16729-458-17 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-458
- Requested NDC
- 16729-458-17
- Package NDCs from labels
- 16729-458-15, 16729-458-17
- Manufacturer
- ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM
- Effective date
- 2026-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine sodium - Accord Healthcare Inc. | Excella GmbH & Co. KG | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Excella GmbH & Co. KG | Intas Pharmaceuticals Limited | 2025-10-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-458-15 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 11 | |
| 16729-458-17 | Levothyroxine sodium | 1000 in 1 BOTTLE | TABLET | 1000 | 11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | ac10b751-5195-4987-a841-400ae79730f0 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 83854522-f22e-491f-8392-c8b1f9441760 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966248 966224 966253 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 645c52bb-c46e-426e-91d4-151aeac975a7 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 65c8b305-8ffb-4aa5-aca1-f4e4ead71a9c | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 633b3f9c-9578-4e07-a515-aec1a8b65e92 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966220 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 0cffbc96-7a02-4538-9966-b69249be6eb2 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e293dd94-b523-47a2-8bed-e6d99945ee59 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 776c8dbc-ca34-40f9-9730-4aa59f644703 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 5c1cf991-6177-499d-a9b8-63e5ca92eb79 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 775ef7ba-0b5b-40ba-ac7b-2aef121fe4f4 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 231fcdf8-c642-4074-8be8-53ee9c918f18 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 251e65e0-6925-4984-9df9-d6d7c6d0703c | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 3142571d-f253-45e7-adc1-6ca80d34cab1 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 513d066a-2fcc-44ad-80e1-23c339a56ac6 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 741a8b30-86e1-4f37-917a-73265a82ee07 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966270 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 1aaa327d-bb10-4815-8bd3-d8c9edc6c9db | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 64a663ac-ac02-4325-8f21-ee212e546121 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 51b68266-95d2-c166-e063-6294a90a534f | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 50fe00b3-6610-1cac-e063-6294a90af8ac | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 5100c561-0028-a3c0-e063-6394a90addeb | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.